NIS to Examine the Effectiveness and Safety of Durvalumab and Olaparib in Patients With Endometrial Cancer (DUOLife)
Clinical trial NCT06890273 · RECRUITING
Trial details
- NCT number
- NCT06890273
- Sponsor
- AstraZeneca
- Status
- RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2025-05-20
- Primary completion
- 2029-03-31
- Enrollment
- 150
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.